David is an intellectual property transactions and data privacy counsel based in Ropes & Gray’s Shanghai office. His practice includes a broad range of intellectual property and general commercial matters, data protection and privacy, and IT. He advises global companies and private equity funds in mergers and acquisitions, foreign direct investments, and commercial transactions involving intellectual property assets. He focuses on licensing arrangements, joint ventures, partnerships, technology transfers, and R&D activities, and assisting clients in the evaluation, monetization, acquisition and disposal of IP assets. David also regularly advises clients on protecting their trademarks, patents, copyrights, trade secrets, and other intellectual property rights in China.
David regularly assists pharmaceutical, biotech, digital health, and medical device companies in their transactions encompassing the entire pharma, biologic, and medical device value chain, including on early-stage collaboration on drug discovery, in-licensing and out-licensing of drug candidates, CMO and CRO arrangements, supply and distribution, and promotion.
David also works with mobile apps, gaming, digital media, and data-driven companies on their transactions involving app, game, and content development and distribution and data sharing.
David has advised clients in the life science, mobile apps, gaming, digital medicine, chemical, education, consumer products, software, consumer electronics, auto, and telecommunications industries. He is a California native and has lived and practiced in China since 2009.